Kura Oncology Inc buy melinda
Start price
06.06.17
/
50%
€8.25
Target price
05.07.17
€9.50
Performance (%)
15.51%
End price
05.07.17
€9.53
Summary
This prediction ended on 05.07.17 with a price of €9.53. The BUY prediction by melinda finished with a performance of 15.51%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kura Oncology Inc | -3.426% | -3.426% | 72.006% | 1.348% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % | 53,70 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % | 76,70 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % | 60,79 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % | 62,81 % |
Comments by melinda for this prediction
In the thread Kura Oncology Inc diskutieren
Anzeige der Phase 2 mit den Daten auf der Konferenz der European Hematology Association (EHA) ab Juni 22-25 2017. Das genaue Datum TBC.
Stopped prediction by melinda for Kura Oncology Inc
Kura Oncology Inc
Start price
Target price
Perf. (%)
€10.64
06.11.18
06.11.18
€14.34
10.12.18
10.12.18
16.15%
10.12.18
10.12.18
Kura Oncology Inc
Start price
Target price
Perf. (%)
€15.33
23.09.18
23.09.18
€16.51
06.11.18
06.11.18
-27.37%
06.11.18
06.11.18
Kura Oncology Inc
Start price
Target price
Perf. (%)
€8.45
10.08.17
10.08.17
€10.50
15.08.17
15.08.17
-25.44%
15.08.17
15.08.17